Infertility Hall A
Friday, November 21, 2014 08:30-10:30
Hot topics: what is the answer?
Debate: The need for LH effects in antagonist protocols Yes: Dominique de Ziegler, France; No: Roy Homburg, Israel Endometriosis, COS response and ART outcome: Chii-Ruey Tzeng, Taiwan The thin endometrium: pathophysiology and treatment options: David Barad, USA
10:30-11:00
Coffee Break
11:00-12:45
Leaders’ Views on the Future: keynote lectures
Opening remarks: Nguyen Viet Tien, Vietnam, Honorary President, Vice Ministry of Health, Chairman of the Vietnam Association of Gynecology, Obstetrics & Family Planning Zeev Shoham, Israel, Congress Co-Chairperson Artificial ovary: Why and how? Marie Madeleine Dolmans, Belgium Artificial gametes: Gerald Schatten, USA The evolving technology of ultrasound in medicine: Israel Shapiro, Israel Producing offspring from artificial gametes: Katsuhiko Hayashi, Japan
12:45-13:30 Lunch 13:30-15:30
Fertility preservation of oocytes and ovarian tissue: an open discussion about the procedures
New aspects in basic research of female fertility preservation: TBA Ovarian freezing and transplantation to preserve fertility in cancer patients provide fertility solutions and raise a lot of controversial issues in addition: Claus Yding Andersen, Denmark Ovarian tissue freezing and grafting: From cancer to benign diseases to social reasons: Jacques Donnez, Belgium Oocyte verification is the best method for fertility preservation: Masashigi Kuwayama, Japan
15:30-16:00
Coffee Break
16:00-18:00 PCOS Debate: With the use of the GnRH agonist trigger (in an antagonist protocol) there is no role for IVM in for the prevention of OHSS For the motion: Seang Lin Tan, Canada; Against the motion: Ho Manh Tuong, Vietnam Individual COS- What is it? Can we apply it? What are the benefits for your practice? Colin M Howles, Switzerland Treatment strategies for the infertile PCO patient: Shahar Kol, Israel
SATURday, November 22, 2014 08:30-10:30 Preimplantation genetic diagnosis & screening – What is it all about?
State of the art of PGD and PGS: Andreas Schmutzler, Germany Does PGS improve IVF outcomes in older women? Simon Fishel, UK Time-lapse imaging: is this the future? Milton Leong, Hong Kong Oocyte- and patient-specific factors influencing embryo morphokinetics and implantation: Simon Fishel, UK
10:30-11:00
Coffee Break
11:00-13:00 Preparing ovaries for IVF in women with low functional ovarian reserve
Improving the prognosis for poor responder patients Molecular changes in ovarian follicles with advancing female age: David Barad, USA Adjusting ovarian stimulation to patient age Is it worthwhile treating women above age 40? Norbert Gleicher, USA Luteal-phase ovarian stimulation in IVF: the present and the future: Yanping Kuang, China IVF outcome in extremely poor prognosis patients: Ariel Weissman, Israel
13:00-14:00 Lunch 14:00-16:00 Unexplained infertility: a challenging condition Debate: Unexplained infertility is caused by early ovarian ageing Pro: Frank Broekmans, The Netherlands; Con: Salim Daya, Canada Debate: COH vs. minimal stimulation: safe stimulation Moderator: John Yovich, Australia Minimal stimulation completely removes the risk of OHSS and has other advantages: Daniel Bodri, Japan Smart COH can avoid OHSS: Frank Broekmans, The Netherlands
16:00-16:30
Coffee Break
16:30-18:30
Adjuvants for poor-prognosis patients
Debate: The re-growth of growth hormones in fertility treatment For: John Yovich, Australia; Against: Roy Homburg, Israel Debate: Does dehydroepiandrosterone (DHEA) supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve? For: Norbert Gleicher, USA; Against: Salim Daya, Canada
GYNECOLOGY Hall B
Friday, November 21, 2014 08:30-10:30 Uterine fibroids: How do we deal with them?
10:30-11:00
Debate: Myomas Progesterone receptor modulation in Fibroids: mode of action: Christian Egarter, Austria The place of medical therapy and particularly UPA: Jacques Donnez, Belgium The place of surgery: Chen Goldchmit, Israel High intensity focused ultrasound in treating uterine fibroids: Vincent Y.T. Cheung, Hong Kong Coffee Break
11:00-12:45
Leaders’ Views on the Future: keynote lectures (hall A)
Opening remarks: Nguyen Viet Tien, Vietnam, Honorary President, Vice Ministry of Health, Chairman of the Vietnam Association of Gynecology, Obstetrics & Family Planning Zeev Shoham, Israel, Congress Co-Chairperson Artificial ovary: Why and how? Marie Madeleine Dolmans, Belgium Artificial gametes: Gerald Schatten, USA The evolving technology of ultrasound in medicine: Israel Shapiro, Israel Producing offspring from artificial gametes: Katsuhiko Hayashi, Japan 12:45-13:30 Lunch 13:30-14:50 Cervical cancer and Human Papilloma Virus (HPV): Does vaccination mark the end of cervical cancer? How do the patients need to be screened? Debate: Should developing countries implement cervical screenings programs or preventive vaccination programs? Pro screening: Lee Shulman, USA; Pro vaccination: Kevin Holcomb, USA Low cost colposcopy: How this fits into the screening process? Elisabeth Wikström Shemer, Sweden 14:50-15:30
Laparoscopic surgical treatment of myona: How careful do we need to be?
The risk of uterine morcellation needs to be considered: A safety warning Case presentation and discussion with the audience: Kevin Holcomb, USA Comments: Ofer Gemer, Israel; Chen Goldchmit, Israel 15:30-16:00 Coffee Break 16:00-17:00
New technologies: do we really need them?
Modern Gyneco-oncological approach Staging of gynecological cancer using the sentile lymph node technique? Alon Ben-Arie, Israel Robotic single-port surgery: Tips and tricks: Kevin Holcomb, USA Internet laparoscopy training: Is it so simple and cost saving? Chen Goldchmit, Israel
SATURday, November 22, 2014 08:30-10:30
Debate: Deep Endometriosis
There is no agreement on the optimal diagnosis of this special types of endometriosis; therefore, the question about which treatment offers longstanding remission for chronic pelvic pain is still being debated Medical therapy: Sun Wei Guo, China; Surgery: Jacques Donnez, Belgium
Women in menopause: Where do we stand today? Debate: Menopausal estrogen therapy Should menopause be defined as a pathological or physical state?: Zeev Shoham, Israel The evidence surrounding the use of botanical interventions in menopause: Lee Shulman, USA Oral vs. Transdermal: John Studd, UK 10:30-11:00 Coffee Break 11:00-13:00 Session 6b: Contraception: Stump the expert Progestogens and estrogens – have we found the ultimate combination? Christian Egarter, Austria Debate: Is the progestogen-only formulation better than the combined formulation in oral contraception Yes: Amos Ber, Israel; No: Lee Shulman, USA Oral contraceptives and folate: Towards a new era in contraception and the prevention of birth defects: Juan Acuna, USA 13:00-14:00 Lunch 14:00-16:00 55th anniversary of the pill: How safe is it?
16:00-16:30
VTE and oral contraception: what we should know: Adolf Schindler, Germany New medicated IUD: a real challenge for young women: Amos Ber, Israel GnRH antagonist: the ultimate method for emergency contraception: Zeev Shoham, Israel Panel discussion: Juan Acuna, USA; Amos Ber, Israel; Christian Egarter, Austria; Adolf Schindler, Germany; Lee Shulman, USA Panel Questions: • New generation pills- are they safe? • Non-stop oral, vaginal and dermal contraception? • What is preferred for emergency contraception: ulipristal, levonorgestrel, IUD, or GnRH antagonist? • Should OC be continued to age 50 and then replaced with HT? • How to deal with irregular/unacceptable bleeding in women using OC – treat and continue, investigate or change the dose? • Where is the androgen in the modern pill? Coffee Break
16:30-18:30 Recurrent pregnancy loss Overview of recurrent pregnancy loss: Salim Daya, Canada Progestogens for prevention/treatment of recurrent pregnancy loss: Adolf Schindler, Germany TBA: Boonsri Chanrachakul, Thailand 18:00-18:30 Severe menstrual bleeding
What should be the treatment: Amos Ber, Israel
ULTRASOUND Hall C
Friday, November 21, 2014 08:30-10:30 Early screening of the fetus (Part I)
The very early anomaly scan: Ruven Achiron, Israel How non-invasive prenatal testing is changing diagnostic algorithms for fetal aneuploidies and genetic disorders: Ashok Khurana, India From Fetopathology to genes: Ruven Achiron, Israel Case presentation: Shlomo Lipitz, Israel
10:30-11:00
Coffee Break
11:00-12:45
Leaders’ Views on the Future: keynote lectures (hall A)
Opening remarks: Nguyen Viet Tien, Vietnam, Honorary President, Vice Ministry of Health, Chairman of the Vietnam Association of Gynecology, Obstetrics & Family Planning Zeev Shoham, Israel, Congress Co-Chairperson Artificial ovary: Why and how? Marie Madeleine Dolmans, Belgium Artificial gametes: Gerald Schatten, USA The evolving technology of ultrasound in medicine: Israel Shapiro, Israel Producing offspring from artificial gametes: Katsuhiko Hayashi, Japan
12:45-13:30 Lunch 13:30-15:30 Early screening of the fetus (Part II)
NT how should it be done? And what should be added: Israel Shapiro, Israel Can NIPT serve as the first line of choice in 1st trimester screening for chromosomal anomalies?: Yuval Yaron, Israel Fetal palate evaluation: 2D or 3D ultrasound evaluation: Ashok Khurana, India Case presentation: Leona Poon, UK
15:30-16:00
Coffee Break
16:00-18:00 Invasive procedures (Part I)
Principle and pitfalls of ultrasound guidance for amniocentesis, CVS and fetal reduction: Israel Shapiro, Israel Fetal posterior urethral valve: Small lesion big consequences: Tuangsit Wataganara, Thailand Monochorionic twins: diagnosis and treatment of specific complications (TTTS, sIUGR): Shlomo Lipitz, Israel Case presentation: The bladder and cloacal exstrophy: Kim Loan Ngo Thi, Vietnam
SATURday, November 22, 2014 08:30-09:30 Invasive procedures (Part II)
Fetal tumors: In utero treatment dilemmas: fetal sclerotherapy in lymphangioma. EXIT in fetal neck tumor, fetal blood transfusion in anemic fetus from vascular tumor, chorioangioma: Tuangsit Wataganara, Thailand Fetal hydrothorax - with and without other chest lesions: diagnosis and treatment: Shlomo Lipitz, Israel
09:30-10:30 Innovations using ultrasound technology
The use of ultrasound and other markers for early detection of preeclampsia: Leona Poon, UK Case presentation: The thin fetus: ultrasound and genetics. Test yourself: Israel Shapiro, Israel Case presentation: Tuangsit Wataganara, Thailand
10:30-11:00
Coffee Break
11:00-13:00
The fetal cardiac system
Basic fetal echocardiography: The basic views: Israel Shapiro, Israel New frontiers in fetocardiovascular imaging: Ruven Achiron, Israel Early fetal cardiac evaluation: false reassurances, false positives and facts: Ashok Khurana, India Case presentation: The “strange eye” panel discussion and expert opinion: Israel Shapiro, Israel
13:00-14:00 Lunch 14:00-16:00
Hot topics in ultrasound screening
Avoid mistakes: Pitfalls and artifacts in 2D and 3D ultrasound including a discussion on 3-D ultrasound: Gimmick or breakthrough? Israel Shapiro, Israel Debate: Universal screening for preterm delivery is by US No: George Daskalakis, Greece; Yes: Leona Poon, UK Diagnosis of central nervous system defects: from US to MRI: Nguyen To HA, Vietnam The use of sonographic imaging in infertile patients: Aris Antsaklis, Greece 16:00-16:30
Coffee Break
16:30-18:30
Gyneco-oncology section: detection of various mass in the pelvis
The role of new ultrasound techniques in the assessment of gynecologic oncology patients: George Daskalakis, Greece The pelvis: various pathological structure: Zvi Appelman, Israel Panel discussion Panel topics: • Can we accurately detect ovarian malignancies by ultrasound? • How to assess women presenting with an adnexal mass • How to scan endometrial cancer practical tips and case presentations • Ovarian cancer staging: the role of US